Characteristic | Total (N = 120) | Group PE (N = 28) | Group PU (N = 17) | p Value (PE vs. PU) | Group TE (N = 34) | Group TU (N = 41) | p Value (TE vs. TU) |
Age, y, Mean ± SD | 70 ± 11 | 65 ± 13 | 66 ± 10 | 0.583 | 71 ± 9 | 73 ± 10 | 0.412 |
Male, % | 70 (84 of 120) | 64 (18 of 28) | 76 (13 of 17) | 0.513 | 74 (25 of 34) | 68 (28 of 41) | 0.799 |
Height, cm, Mean ± SD | 160.4 ± 10.5 | 162.1 ± 10.3 | 159.8 ± 14.2 | 0.532 | 160.8 ± 8.9 | 162.1 ± 10.6 | 0.589 |
Weight, kg, Mean ± SD | 60 ± 14 | 58.8 ± 15.4 | 60.5 ± 14.4 | 0.732 | 61.6 ± 12.6 | 59.9 ± 14.3 | 0.575 |
BMI, kg/m2, Mean ± SD | 23 ± 4 | 22 ± 4 | 23 ± 1 | 0.27 | 24 ± 4 | 23 ± 4 | 0.262 |
Marfan Syndrome, % | 3 (3 of 120) | 11 (3 of 28) | 0 (0 of 17) | - | 0 (0 of 34) | 0 (0 of 41) | - |
COPD, % | 38 (32 of 120) | 43 (12 of 28) | 35 (6 of 17) | 0.757 | 29 (10 of 34) | 26 (10 of 39) | 0.796 |
Follow-Up Period, Months, Mean ± SD | 57 ± 43 | 64 ± 45 | 42 ± 38 | 0.093 | 65 ± 43 | 51 ± 41 | 0.159 |